WCAX-TV: St. Johnsbury woman finds hope in new pancreatic cancer drug after losing husband (AUG 31, 2026)
Randall Holcombe, M.D., M.B.A., director of the University of Vermont Cancer Center, comments on a new drug approved by the FDA as a treatment for pancreatic cancer. In trials, the drug—which targets the gene mutation fueling the cancer’s growth—helped patients live up to a year longer than other treatments alone.
Additional media coverage: NBC5